Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 2,544 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Stroke Patients, CPAP, OSA - Obstructive Sleep Apnea
Interventions: CPAP device, CPAP technical support, Phone follow-up for adherence feedback and self-management skills, myAir, Tailored messages, Written Materials, Motivational Enhancement Therapy (MET); Device · Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Downey, California • Seattle, Washington

Conditions: Sleep
Interventions: LED portable light therapy bulb; Other
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Restless Legs Syndrome, Insomnia, Sleep Disorder
Interventions: Suvorexant, Placebo; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 25 Years to 85 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anxiety Disorders, Mood Disorders, Insomnia, Nightmares
Interventions: Behavioral Sleep Intervention, Prazosin, Placebo; Behavioral · Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 55 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alzheimer Disease, Sleep Initiation and Maintenance Disorders
Interventions: Walking Program, Light Exposure Program, Combined Education, Walking and Light Exposure Program, Routine Medical Care with Education; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 55 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Insomnia, Mild Cognitive Impairment
Interventions: Cognitive Training, Trivia Training; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 60 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Sleep Apnea, Obstructive
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sleep, Insomnia, Sleep Deprivation
Interventions: Sleep Restriction; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Headache Disorder, Sleep Disorder, Obstructive Sleep Apnea
Interventions: Continuous positive airway pressure (CPAP); Device
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Insomnia
Interventions: Ramelteon, Usual Care; Drug · Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Lung Cancers
Interventions: bright light; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Insomnia, Metabolic Health, Menopause
Interventions: Suvorexant, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain, Anxiety, Depression, Sleeplessness
Interventions: Nu-V3; Device
Lead sponsor: Nu-Life Solutions; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Schaumburg, Illinois • Greenwood, Indiana

Conditions: Stroke, Traumatic Brain Injury, Non-traumatic Brain Injury
Interventions: Philips GoLite Blu HF3429/60, Philips LivingColor Aura 70998/60/48; Other
Lead sponsor: St. Luke's Rehabilitation Institute; Other
Eligibility: 18 Years to 85 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Delirium in Old Age
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 65 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obstructive Sleep Apnea
Interventions: Encore System; Device
Lead sponsor: Abidin, Michael, M.D.; Individual
Eligibility: 20 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Alexandria, Virginia

Conditions: Atrial Fibrillation
Interventions: MyTAP oral appliance plus mouth shield; Device
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Bipolar Disorder, Sleep Problems, Suicidal Thoughts
Interventions: Brief Sleep Intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Apnea, Obstructive Sleep Apnea, Postoperative Complications
Interventions: Ketamine, Control; Drug · Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 100 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Insomnia
Interventions: zolpidem tartrate; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 21 Years to 64 Years
Enrollment: 372 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Sleep Apnea, Obstructive, Total Knee Arthroplasty, Total Hip Arthroplasty
Interventions: Evaluation by Sleep Medicine Specialists; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Insomnia Chronic
Interventions: Nutritional Education, Physical Activity; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Jacksonville, Florida

Conditions: Advanced Malignant Solid Neoplasm, Delirium, Hematopoietic and Lymphatic System Neoplasm, Insomnia
Interventions: Best Practice, Electronic Health Record Review, Interview, Questionnaire Administration, Suvorexant; Other · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Chronic Fatigue Syndrome, Behavioral Therapy Targeted to Sleep Problems
Interventions: Cognitive Behavioral Therapy, Usual Care for Chronic Fatigue Syndrome (Active Control Group); Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

Effects of Combined Blue and Red Home-Based Light Therapy on Sleep in Adults With Self-Reported Sleep Difficulties

Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia

Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)

Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease

Cognitive Training in Mild Cognitive Impairment

Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep

The Effect of Sleep Loss on Emotion Regulation

Analysis of the Prevalence and Characteristics of Concomitant Sleep and Headache Disorders, and the Efficacy of CPAP Treatment for Headache Among Those Patients Diagnosed With Obstructive Sleep Apnea

Ramelteon for Complex Insomnia in Veterans With PTSD

Bright Light Therapy on Sleep Health in Lung Cancer Patients

Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia

Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness

Daily Light Exposure for Sleep Disturbance, Fatigue, and Functional Outcomes in Acute Brain Injury

Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults

Hyoid Suspension to the Mandible for the Treatment of Obstructive Sleep Apnea

Effect of Oral Appliance Therapy on Atrial Fibrillation

Brief Sleep Intervention for Bipolar Disorder

Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea

Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)

Obstructive Sleep Apnea in Elective Orthopaedic Surgery

Subjective Sleep Quality of Patients With Chronic Insomnia

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Behavioral Insomnia Therapy With Chronic Fatigue Syndrome